Portal de Periódicos da CAPES

Performance Evaluation of the GlucoDr Plus Glucometer

2010; Mary Ann Liebert, Inc.; Volume: 12; Issue: 4 Linguagem: Inglês

10.1089/dia.2009.0134

1557-8593

Dae‐Hyun Ko, Soo Lim, Sang Hoon Song, Sung Hee Choi, Young Joo Park, Kyoung Un Park, Hak Chul Jang, Junghan Song,

Diabetes Management and Education

Because strict glucose control is important for reducing the complications of diabetes, the self-monitoring of blood glucose is one of the fundamental treatment modalities. Many glucometers have been developed. In the present study, we evaluated a new glucometer: GlucoDr Plus (Allmedicus, Anyang, Gyeonggi-do, Republic of Korea).The evaluation was performed based on Clinical and Laboratory Standards Institute guidelines. Interferences by ascorbic acid, uric acid, maltose, and acetaminophen were examined, and the performance of the unit was compared to those of six other glucometers. The effects of hematocrit, of oxygen partial pressure (PaO(2)), and of multiple users were also evaluated.Within-run, between-run, between-day, and total imprecision (coefficients of variation) were 0.99-4.98%. Satisfactory linearity was found for glucose concentrations of 32.5-786.5 mg/dL (R(2) = 0.9985). A comparison with the reference laboratory method showed close concordance over the entire range of concentrations evaluated (R(2) = 0.9869). No significant effects were noted due to added interferents, hematocrit, and PaO(2).The GlucoDr Plus showed acceptable performance in terms of precision and linearity. It was minimally affected by various interferents. GlucoDr Plus is suitable for the self-monitoring of blood glucose by patients with diabetes.